Daly James M — SEC Form 4 filings

SEC reporting owner CIK 1560782. 14 Form 4 filings on record with FilingPulse; latest filed 2026-07-16.

Transaction summary — filings shown

Covers all 14 filings on record, filed 2024-04-03 to 2026-07-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
MADRIGAL PHARMACEUTICALS, INC. (MDGL)Director519 legs · 47,959 sh · $13,593,75616
ACADIA PHARMACEUTICALS INC (ACAD)Director41 leg · 30,000 sh · $670,98312
CYTOKINETICS INC (CYTK)Director56

Form 4 filings — Daly James M

FiledFormIssuerReported transactionsSource
2026-07-164CYTOKINETICS INC (CYTK)Grant/award (A): 151 @ $82.62EDGAR
2026-06-184MADRIGAL PHARMACEUTICALS, INC. (MDGL)Grant/award (A): 454 @ $0 · Grant/award (A): 766 (derivative) @ $0EDGAR
2026-06-014ACADIA PHARMACEUTICALS INC (ACAD)Option exercise (M): 8,107 · Option exercise (M): 8,107 (derivative) @ $0 · Grant/award (A): 16,004 (derivative) @ $0 · Grant/award (A): 9,311 (derivative) @ $0EDGAR
2026-05-274CYTOKINETICS INC (CYTK)Grant/award (A): 2,851 @ $0 · Grant/award (A): 4,301 (derivative) @ $0EDGAR
2026-04-154CYTOKINETICS INC (CYTK)Grant/award (A): 191 @ $65.37EDGAR
2026-01-204CYTOKINETICS INC (CYTK)Grant/award (A): 197 @ $63.44EDGAR
2025-11-124ACADIA PHARMACEUTICALS INC (ACAD)Sale (S): 30,000 @ $22.37EDGAR
2025-08-204CYTOKINETICS INC (CYTK)Grant/award (A): 27,450 (derivative) @ $0EDGAR
2025-06-244MADRIGAL PHARMACEUTICALS, INC. (MDGL)Grant/award (A): 715 @ $0 · Grant/award (A): 1,290 (derivative) @ $0EDGAR
2025-06-024ACADIA PHARMACEUTICALS INC (ACAD)Option exercise (M): 9,387 · Option exercise (M): 9,387 (derivative) @ $0 · Grant/award (A): 13,793 (derivative) @ $0 · Grant/award (A): 8,107 (derivative) @ $0EDGAR
2025-02-284MADRIGAL PHARMACEUTICALS, INC. (MDGL)Option exercise (M): 9,470 @ $65.06 · Option exercise (M): 6,000 @ $111.06 · Sale (S): 398 @ $346.90 · Sale (S): 14,302 @ $347.39 · Sale (S): 770 @ $348.94 · Option exercise (M): 9,470 (derivative) @ $0 · +1 moreEDGAR
2024-06-274MADRIGAL PHARMACEUTICALS, INC. (MDGL)Grant/award (A): 714 @ $0 · Grant/award (A): 1,105 (derivative) @ $0EDGAR
2024-05-314ACADIA PHARMACEUTICALS INC (ACAD)Option exercise (M): 6,652 · Option exercise (M): 6,652 (derivative) @ $0 · Grant/award (A): 15,959 (derivative) @ $0 · Grant/award (A): 9,387 (derivative) @ $0EDGAR
2024-04-034MADRIGAL PHARMACEUTICALS, INC. (MDGL)Option exercise (M): 20,000 @ $100.45 · Option exercise (M): 1,577 @ $105.08 · Sale (S): 6,809 @ $255.64 · Sale (S): 7,401 @ $256.50 · Sale (S): 3,604 @ $257.30 · Sale (S): 1,460 @ $258.28 · +16 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1560782 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →